AAAAAA
Results: 1-25/28
Authors:
PARK G
LU FH
YE N
BRECHBIEL MW
TORTI SV
TORTI FM
PLANALP RP
Citation: G. Park et al., NOVEL IRON COMPLEXES AND CHELATORS BASED ON CIS,CIS-1,3,5-TRIAMINOCYCLOHEXANE - IRON-MEDIATED LIGAND OXIDATION AND BIOCHEMICAL-PROPERTIES, JBIC. Journal of biological inorganic chemistry, 3(5), 1998, pp. 449-457
Authors:
TORTI SV
AKIMOTO H
LIN K
BILLINGHAM ME
TORTI FM
Citation: Sv. Torti et al., SELECTIVE-INHIBITION OF MUSCLE GENE-EXPRESSION BY OXIDATIVE STRESS INCARDIAC-CELLS, Journal of Molecular and Cellular Cardiology, 30(6), 1998, pp. 1173-1180
Authors:
TSUJI Y
TORTI SV
TORTI FM
Citation: Y. Tsuji et al., ACTIVATION OF THE FERRITIN-H ENHANCER, FER-1, BY THE COOPERATIVE ACTION OF MEMBERS OF THE AP1 AND SP1 TRANSCRIPTION FACTOR FAMILIES, The Journal of biological chemistry, 273(5), 1998, pp. 2984-2992
Authors:
TORTI SV
TORTI FM
Citation: Sv. Torti et Fm. Torti, HUMAN H-KININOGEN IS A FERRITIN-BINDING PROTEIN, The Journal of biological chemistry, 273(22), 1998, pp. 13630-13635
Authors:
TORTI SV
TORTI FM
WHITMAN SP
BRECHBIEL MW
PARK G
PLANALP RP
Citation: Sv. Torti et al., TUMOR-CELL CYTOTOXICITY OF A NOVEL METAL CHELATOR, Blood, 92(4), 1998, pp. 1384-1389
Authors:
BRINKLEY WM
TORTI FM
Citation: Wm. Brinkley et Fm. Torti, SYSTEMIC CHEMOTHERAPY OF TRANSITIONAL-CELL CARCINOMA OF THE UROTHELIUM, Seminars in surgical oncology, 13(5), 1997, pp. 365-375
Authors:
RUCKER P
TORTI FM
TORTI SV
Citation: P. Rucker et al., RECOMBINANT FERRITIN - MODULATION OF SUBUNIT STOICHIOMETRY IN BACTERIAL EXPRESSION SYSTEMS, Protein engineering, 10(8), 1997, pp. 967-973
Authors:
MILLER SC
TAYLOR A
WATANABE K
MOK K
TORTI FM
Citation: Sc. Miller et al., REGULATION OF NF-KAPPA-B AND HIV-1 LTR ACTIVITY IN MOUSE L-CELL BY ULTRAVIOLET-RADIATION - LTR TRANSACTIVATION IN A NONIRRADIATED GENOME INHETEROKARYONS, Experimental cell research, 230(1), 1997, pp. 9-21
Authors:
FREIHA F
REESE J
TORTI FM
Citation: F. Freiha et al., A RANDOMIZED TRIAL OF RADICAL CYSTECTOMY VERSUS RADICAL CYSTECTOMY PLUS CISPLATIN, VINBLASTINE AND METHOTREXATE CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER-CANCER, The Journal of urology, 155(2), 1996, pp. 495-499
Authors:
FREIHA F
REESE J
TORTI FM
Citation: F. Freiha et al., A RANDOMIZED TRIAL OF RADICAL CYSTECTOMY VERSUS RADICAL CYSTECTOMY PLUS CISPLATIN, VINBLASTINE AND METHOTREXATE CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER-CANCER - REPLY, The Journal of urology, 155(2), 1996, pp. 500-500
Authors:
RUCKER P
TORTI FM
TORTI SV
Citation: P. Rucker et al., ROLE OF H-SUBUNIT AND L-SUBUNIT IN MOUSE FERRITIN, The Journal of biological chemistry, 271(52), 1996, pp. 33352-33357
Authors:
BEAUMONT C
TORTI SV
TORTI FM
MASSOVER WH
Citation: C. Beaumont et al., NOVEL PROPERTIES OF L-TYPE POLYPEPTIDE SUBUNITS IN MOUSE FERRITIN MOLECULES, The Journal of biological chemistry, 271(14), 1996, pp. 7923-7926
Authors:
LAMM DL
TORTI FM
Citation: Dl. Lamm et Fm. Torti, BLADDER-CANCER, 1996, Ca, 46(2), 1996, pp. 93-112
Authors:
ABRUZZESE E
RADFORD JE
PETTENATI MJ
RAO PN
HURD DD
RAINER RO
POWELL BL
TORTI FM
Citation: E. Abruzzese et al., CD34 POSITIVE PROGENITORS CAN BE CYTOGENETICALLY NORMAL IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS), Blood, 88(10), 1996, pp. 1906-1906
Authors:
PARKANYI C
POLITZER P
COFFEY RJ
FUQUA SAW
TORTI FM
Citation: C. Parkanyi et al., 17TH ANNUAL INTERDISCIPLINARY CANCER-RESEARCH WORKSHOP, Cancer biochemistry biophysics, 15(1), 1995, pp. 49-54
Authors:
TSUJI Y
AKEBI N
LAM TK
NAKABEPPU Y
TORTI SV
TORTI FM
Citation: Y. Tsuji et al., FER-1, AN ENHANCER OF THE FERRITIN-H GENE AND A TARGET OF E1A-MEDIATED TRANSCRIPTIONAL REPRESSION, Molecular and cellular biology, 15(9), 1995, pp. 5152-5164
Authors:
KWAK EL
LAROCHELLE DA
BEAUMONT C
TORTI SV
TORTI FM
Citation: El. Kwak et al., ROLE FOR NF-KAPPA-B IN THE REGULATION OF FERRITIN-H BY TUMOR-NECROSIS-FACTOR-ALPHA, The Journal of biological chemistry, 270(25), 1995, pp. 15285-15293
Authors:
ABRUZZESE E
RAO PN
HAYWORTH R
PETTENATI MJ
TORTI SV
TORTI FM
Citation: E. Abruzzese et al., UTILIZATION OF FLUORESCENCE IN-SITU HYBRIDIZATION TO STUDY THE FERRITIN-H GENE-EXPRESSION IN METAPHASE AND INTERPHASE CELLS, Blood, 86(10), 1995, pp. 2878-2878
Authors:
TERRIS MK
EIGNER EB
BRIGGS EM
REESE JH
TORTI FM
FREIHA FS
Citation: Mk. Terris et al., TRANSRECTAL ULTRASOUND IN THE EVALUATION OF RHABDOMYOSARCOMA INVOLVING THE PROSTATE, British Journal of Urology, 74(3), 1994, pp. 341-344
Authors:
WARREN S
TORTI SV
TORTI FM
Citation: S. Warren et al., THE ROLE OF IRON IN THE CYTOTOXICITY OF TUMOR-NECROSIS-FACTOR, Lymphokine and cytokine research, 12(2), 1993, pp. 75-80
Authors:
WRIGHT SC
ZHENG H
ZHONG J
TORTI FM
LARRICK JW
Citation: Sc. Wright et al., ROLE OF PROTEIN-PHOSPHORYLATION IN TNF-INDUCED APOPTOSIS - PHOSPHATASE INHIBITORS SYNERGIZE WITH TNF TO ACTIVATE DNA FRAGMENTATION IN NORMAL AS WELL AS TNF-RESISTANT U937 VARIANTS, Journal of cellular biochemistry, 53(3), 1993, pp. 222-233
Authors:
SCHRODER H
WARREN S
BARGETZI MJ
TORTI SV
TORTI FM
Citation: H. Schroder et al., N-ACETYL-L-CYSTEINE PROTECTS ENDOTHELIAL-CELLS BUT NOT L929 TUMOR-CELLS FROM TUMOR NECROSIS FACTOR-ALPHA-MEDIATED CYTOTOXICITY, Naunyn-Schmiedeberg's archives of pharmacology, 347(6), 1993, pp. 664-666
Authors:
NINOMIYATSUJI J
TORTI FM
RINGOLD GM
Citation: J. Ninomiyatsuji et al., TUMOR NECROSIS FACTOR-INDUCED C-MYC EXPRESSION IN THE ABSENCE OF MITOGENESIS IS ASSOCIATED WITH INHIBITION OF ADIPOCYTE DIFFERENTIATION, Proceedings of the National Academy of Sciences of the United Statesof America, 90(20), 1993, pp. 9611-9615
Authors:
MILLER RS
FREIHA FS
REESE JH
OZEN H
TORTI FM
Citation: Rs. Miller et al., CISPLATIN, METHOTREXATE AND VINBLASTINE PLUS SURGICAL RESTAGING FOR PATIENTS WITH ADVANCED TRANSITIONAL-CELL CARCINOMA OF THE UROTHELIUM, The Journal of urology, 150(1), 1993, pp. 65-69
Authors:
MOHTAI M
SMITH RL
SCHURMAN DJ
TSUJI Y
TORTI FM
HUTCHINSON NI
STETLERSTEVENSON WG
GOLDBERG GI
Citation: M. Mohtai et al., EXPRESSION OF 92-KD TYPE-IV COLLAGENASE GELATINASE (GELATINASE-B) IN OSTEOARTHRITIC CARTILAGE AND ITS INDUCTION IN NORMAL HUMAN ARTICULAR-CARTILAGE BY INTERLEUKIN-1, The Journal of clinical investigation, 92(1), 1993, pp. 179-185